ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
71 hedge funds and large institutions have $22.5M invested in Elevation Oncology in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 11 closing their positions.
Holders
71
Holders Change
+3
Holders Change %
+4.41%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
26
Reduced
13
Closed
11
Calls
$1K
Puts
$2K
Net Calls
-$1K
Net Calls Change
+$30K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$150K |
| 2 |
2
BlackRock
New York
|
$1.78M |
| 3 |
SCM
3
Stonepine Capital Management
Bend,
Oregon
|
$113K |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$106K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$101K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Simplex Trading
Chicago,
Illinois
| – | -$11K | -19,500 | Closed |
|
|
EGM
77
Engineers Gate Manager
New York
| – | -$8.18K | -13,631 | Closed |
|
|
PCM
78
Prelude Capital Management
New York
| – | -$7.34K | -12,240 | Closed |
|
79
Mercer Global Advisors
Denver,
Colorado
| – | -$5.62K | -10,025 | Closed |
|
|
SO
80
STRS Ohio
Columbus,
Ohio
| – | -$5.82K | -9,700 | Closed |
|
|
CPA
81
Capital Performance Advisors
Walnut Creek,
California
| – | -$7 | -11 | Closed |
|